Please wait...
About This Project
Oxidized forms of the peptide beta-amyloid (Aβ) are considered to be toxic to the brain, leading to the development of Alzheimer's disease (AD). Based on our preliminary data, we hypothesize that an immunization of an AD-model mice with a recombinant protein enriched with the oxidized amino acid methionine sulfoxide will cause the removal of toxic Aβ from brain. Consequently, this treatment is expected to inhibit the development of AD and alleviate cognitive impairment.
More Lab Notes From This Project
Browse Other Projects on Experiment
Related Projects
Can a rabies vaccination booster save African Wild Dogs?
Rabies is one of the greatest threats to the continued survival of the African wild dog (Lycaon pictus...
Can cockroaches help us cure tularemia?
Tularemia is a deadly disease caused by the bacterium Francisella tularensis (Ft). This bacterium is also...
Crowdcuring the Blues: People, Technology and Research Against Depression
Depression is not a choice, but we can choose to do something about it. Depression is a single label used...